Category: Immunologic Implantation Dysfunction

Management of Immunologic Implantation Dysfunction (IID)

In the United States, effective treatment of NK/CTL activation associated with either alloimmune or autoimmune implantation dysfunction requires the administration of primarily Intralipid (IL). Such treatment is much more likely to be successful in the case of` autoimmune implantation dysfunction Read more